We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Microscan Demonstrates Advanced Technology at Scientific Meeting

By LabMedica International staff writers
Posted on 01 Aug 2017
Print article
Image: The MicroHAWK platform for barcode reading and machine vision (Photo courtesy of Microscan Systems).
Image: The MicroHAWK platform for barcode reading and machine vision (Photo courtesy of Microscan Systems).
Microscan Systems, Inc. (Renton, WA, USA), a provider of embedded clinical barcode readers and machine vision solutions for life sciences, demonstrated advancements of its MicroHAWK platform for barcode reading and machine vision, LVS label verification, and print quality inspection systems at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo, the world’s largest exposition for clinical laboratory products and services.

Microscan’s barcode reading, machine vision, and verification technology serves a wide range of automation and OEM applications and the company’s solutions range from barcode reading, tracking, and traceability to complex machine vision measurement, guidance, barcode verification, and print quality grading. The company was among over 750 exhibitors who displayed pioneering diagnostic technology, including the latest in mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation at the 2017 AACC Clinical Lab Expo held at the San Diego Convention Center from August 1-3.

Microscan’s MicroHAWK platform provides users a single hardware solution with options to meet any barcode decoding or inspection task, in any integration space, and with scalability to meet unique current and future requirements. The hardware has been designed with life science and OEM applications in mind, focused on specific feature customizations in enclosed devices that can be manufactured and supported by Microscan on a long-term basis to accommodate instrument lifecycles.

The company’s miniaturization technology allows medical device manufacturers, laboratories, and OEMs to use MicroHAWK devices in the most space-constrained installations. For instance, the extremely small size of MicroHAWK smart cameras enables them to be easily embedded for automating processes such as specimen and reagent identification, tracking labware presence and absence, cap type and color identification, dimensional measurements such as tube height and diameter, automated alignment and robotic guidance within turnkey medical devices and instruments.

MicroHAWK barcode readers, which were on display at the event, are equipped with Autofocus technology, enabling flexible positioning in medical equipment and other integration environments. MicroHAWK with Autofocus can read symbols at any distance, while fixed-focus models are factory-configured to decode at set focal distances. Autofocus models offer both an automatic autofocus for continuous symbol location and decoding, as well as software-programmable focus - which allows users the option to set fixed focal distances for Autofocus units from Microscan’s Weblink software user interface. Through direct integration of the Autofocus lens technology into MicroHAWK, Microscan eliminates additional cost to the user, minimizes device size, avoids integration complexity and removes the need for additional optical accessories.

Also on display was Microscan’s LVS-9580 Handheld Barcode Verifier - a high-performance handheld solution for off-line barcode verification to ISO/IEC and GS-1 standards. The LVS-9580 reads and analyzes multiple types of linear (1D) and two-dimensional (2D) barcodes up to 3.0 inches (76.19 mm) wide and up to 2.25 inches (57.15 mm) tall, located on a wide range of surfaces. It enables users to test newly designed labels for quality and compliance issues before printing.

Microscan also ran live demonstrations of its LVS-7510 Print Quality Inspection System, configurable into manufacturing lines and printers to check label accuracy on the fly during label printing. It is used for 100% label inspection including 1D/2D barcode verification, OCR, serialization and blemish detection in medical device manufacturing, packaging and other industries. The LVS-7510 identifies errors in code readability and compliance as codes are printed, allowing manufacturers to address printing or formatting issues before incurring fines and scrapped product down the supply chain. Both in-line and off-line verification solutions address the growing need for compliance to the FDA’s Unique Device Identification (UDI) initiative, GS1 and HIBCC data structure, as well as other regulated barcoding and product serialization standards.

Related Links:
Microscan Systems

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.